Skip to main content

Table 2 Correlation between MembErbB-2 prevalence detected by immunohistochemistry

From: Clinical relevance of ErbB-2/HER2 nuclear expression in breast cancer

Antibody MembErbB-2, n(%) Total N (%)
  Negative Positive  
RBT-HER2 175 (87.1) 26 (12.9) 201
A0485 181(86.2) 29 (13.8) 210
C-18 177 (87.6) 25 (12.4) 202
  1. Because of the absence of some core sections on the slides, 201 patient samples could be analyzed for MembErbB-2 with RBT-HER2, 210 with A0485, and 202 with C-18. Scores of 3+ and only those of 2+ in which FISH confirmed ErbB-2 amplification were considered positive for MembErbB-2 overexpression